From opera to breakdancing and back again Jakub Jzef Orliski ... - WBUR News

NUNZ Stock  USD 0  0.00  0.00%   
Slightly above 67% of Nunzia Pharmaceutical's investor base is looking to short. The analysis of overall sentiment of trading Nunzia Pharmaceutical pink sheet suggests that many investors are alarmed at this time. Nunzia Pharmaceutical's investing sentiment can be driven by a variety of factors including economic data, Nunzia Pharmaceutical's earnings reports, geopolitical events, and overall market trends.
  
From opera to breakdancing and back again Jakub Jzef Orliski ... WBUR News

Read at news.google.com
Google News at Macroaxis
  

Nunzia Pharmaceutical Fundamental Analysis

We analyze Nunzia Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nunzia Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nunzia Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Beta

Beta Comparative Analysis

Nunzia Pharmaceutical is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Peers

Trending Equities

AAPL  0.94   
0%
19.0%
T  0.82   
0%
16.0%
CVX  0.65   
0%
13.0%
MET  0.48   
0%
9.0%
C  0.13   
0%
2.0%
HD  0.34   
6.0%
0%
S  0.50   
10.0%
0%
WFC  1.03   
21.0%
0%
AAL  1.16   
23.0%
0%
IBM  1.65   
33.0%
0%
CVS  1.78   
36.0%
0%
UPS  1.88   
38.0%
0%
TGT  3.05   
62.0%
0%
INTC  3.28   
67.0%
0%
AA  3.42   
69.0%
0%
BBY  4.89   
100.0%
0%

Additional Tools for Nunzia Pink Sheet Analysis

When running Nunzia Pharmaceutical's price analysis, check to measure Nunzia Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nunzia Pharmaceutical is operating at the current time. Most of Nunzia Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Nunzia Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nunzia Pharmaceutical's price. Additionally, you may evaluate how the addition of Nunzia Pharmaceutical to your portfolios can decrease your overall portfolio volatility.